ERBB2 and cancer: In a recent meta-analysis investigating the relation between HER2 expression and clinicopathologic features of UC, a correlation with carcinoma in situ, multifocality, tumor size, grade, stage, lymph node metastases, progression, and recurrence was observed [93].